标题
Novel skeletal effects of glucagon-like peptide-1 (GLP-1) receptor agonists
作者
关键词
-
出版物
JOURNAL OF ENDOCRINOLOGY
Volume 236, Issue 1, Pages R29-R42
出版商
Bioscientifica
发表日期
2017-08-31
DOI
10.1530/joe-17-0278
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Exendin-4, a glucagon-like peptide-1 analogue, accelerates diabetic wound healing
- (2017) Jun-Neng Roan et al. JOURNAL OF SURGICAL RESEARCH
- Is Diabetic Skeletal Fragility Associated with Microvascular Complications in Bone?
- (2017) Roberto Jose Fajardo Current Osteoporosis Reports
- Exendin-4 Upregulates Adiponectin Level in Adipocytes via Sirt1/Foxo-1 Signaling Pathway
- (2017) Anping Wang et al. PLoS One
- High fat-fed diabetic mice present with profound alterations of the osteocyte network
- (2016) Guillaume Mabilleau et al. BONE
- Effects of glucagon-like peptide-1 on the differentiation and metabolism of human adipocytes
- (2016) Rajaa El Bekay et al. BRITISH JOURNAL OF PHARMACOLOGY
- The Activity of Adiponectin in Bone
- (2016) Dorit Naot et al. CALCIFIED TISSUE INTERNATIONAL
- How Accurate is Your Sclerostin Measurement? Comparison Between Three Commercially Available Sclerostin ELISA Kits
- (2016) Isabelle Piec et al. CALCIFIED TISSUE INTERNATIONAL
- Skeletal Metabolism, Fracture Risk, and Fracture Outcomes in Type 1 and Type 2 Diabetes
- (2016) Deborah E. Sellmeyer et al. DIABETES
- COMPARISON OF THE LONG-TERM EFFECTS OF LIRAGLUTIDE AND GLIMEPIRIDE MONOTHERAPY ON BONE MINERAL DENSITY IN PATIENTS WITH TYPE 2 DIABETES
- (2016) Matthew P. Gilbert et al. Endocrine Practice
- Basal and stimulated calcitonin levels in patients with type 2 diabetes did not change during 1 year of Liraglutide treatment
- (2016) Maria Elena Lunati et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Mechanisms of diabetes mellitus-induced bone fragility
- (2016) Nicola Napoli et al. Nature Reviews Endocrinology
- Sclerostin does not play a major role in the pathogenesis of skeletal complications in type 2 diabetes mellitus
- (2016) M. Pereira et al. OSTEOPOROSIS INTERNATIONAL
- Perspectives in GLP-1 Research: New Targets, New Receptors
- (2016) Giulia Cantini et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
- Blood flow controls bone vascular function and osteogenesis
- (2016) Saravana K. Ramasamy et al. Nature Communications
- Incretin-Based Therapy for Prevention of Diabetic Vascular Complications
- (2016) Akira Mima Journal of Diabetes Research
- Activation of GLP-1 Receptor Promotes Bone Marrow Stromal Cell Osteogenic Differentiation through β-Catenin
- (2016) Jingru Meng et al. Stem Cell Reports
- Protective Effects of Vildagliptin against Pioglitazone-Induced Bone Loss in Type 2 Diabetic Rats
- (2016) Young Sil Eom et al. PLoS One
- Effect of exenatide, insulin and pioglitazone on bone metabolism in patients with newly diagnosed type 2 diabetes
- (2015) Renyuan Li et al. ACTA DIABETOLOGICA
- GLP-1 Receptor Agonist Exenatide Increases Capillary Perfusion Independent of Nitric Oxide in Healthy Overweight Men
- (2015) M. M. Smits et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cells
- (2015) Ken-ichiro Tanaka et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Chronic administration of Glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice
- (2015) M. Pereira et al. BONE
- Use of Glucagon-Like-Peptide 1 Receptor Agonists and Risk of Fracture as Compared to Use of Other Anti-hyperglycemic Drugs
- (2015) Johanna H. M. Driessen et al. CALCIFIED TISSUE INTERNATIONAL
- Bone Fracture Risk is Not Associated with the Use of Glucagon-Like Peptide-1 Receptor Agonists: A Population-Based Cohort Analysis
- (2015) Johanna H. M. Driessen et al. CALCIFIED TISSUE INTERNATIONAL
- Acute hemodynamic and renal effects of glucagon-like peptide 1 analog and dipeptidyl peptidase-4 inhibitor in rats
- (2015) Xiaoyan Zhou et al. Cardiovascular Diabetology
- Efficacy and safety of liraglutide monotherapy compared with metformin in Japanese overweight/obese patients with type 2 diabetes
- (2015) Kumiko Tanaka et al. ENDOCRINE JOURNAL
- The effects of insulin and liraglutide on osteoprotegerin and vascular calcification in vitro and in patients with type 2 diabetes
- (2015) C. Davenport et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Effect of dipeptidyl peptidase-4 inhibition on circadian blood pressure during the development of salt-dependent hypertension in rats
- (2015) Abu Sufiun et al. HYPERTENSION RESEARCH
- Modulation of Glucagon Receptor Pharmacology by Receptor Activity-modifying Protein-2 (RAMP2)
- (2015) Cathryn Weston et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Stable Incretin Mimetics Counter Rapid Deterioration of Bone Quality in Type 1 Diabetes Mellitus
- (2015) Sity Aishah Mansur et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Letter to the Editor: “GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese Women” by Iepsen E.W., et al
- (2015) Caterina Conte et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Circulating Progenitor Cell Count Predicts Microvascular Outcomes in Type 2 Diabetic Patients
- (2015) Mauro Rigato et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- GLP-1 Receptor Agonist Treatment Increases Bone Formation and Prevents Bone Loss in Weight-Reduced Obese Women
- (2015) Eva W. Iepsen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effect of liraglutide on proliferation and differentiation of human adipose stem cells
- (2015) Giulia Cantini et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Liraglutide, the glucagon-like peptide-1 receptor agonist, has anabolic bone effects in diabetic Goto-Kakizaki rats 利拉鲁肽，一种胰高血糖素样肽-1受体激动剂，在糖尿病Goto-Kakizaki大鼠中具有骨合成代谢作用
- (2015) Han-xiao Sun et al. Journal of Diabetes
- Glucagon-like peptide-1 receptor agonist Liraglutide has anabolic bone effects in ovariectomized rats without diabetes.
- (2015) Nan Lu et al. PLoS One
- DPP IV inhibitor treatment attenuates bone loss and improves mechanical bone strength in male diabetic rats
- (2014) Lorenzo Glorie et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Use of dipeptidyl peptidase-4 inhibitors for type 2 diabetes mellitus and risk of fracture
- (2014) Johanna H.M. Driessen et al. BONE
- Exenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway
- (2014) Jun-Kun Zhan et al. Cardiovascular Diabetology
- Expression of glucagon-like peptide-1 receptor and glucose-dependent insulinotropic polypeptide receptor is regulated by the glucose concentration in mouse osteoblastic MC3T3-E1 cells
- (2014) EMINA AOYAMA et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Double incretin receptor knock-out (DIRKO) mice present with alterations of trabecular and cortical micromorphology and bone strength
- (2014) A. Mieczkowska et al. OSTEOPOROSIS INTERNATIONAL
- Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and quality
- (2013) Aleksandra Mieczkowska et al. BONE
- Effects of age on bone mRNA levels of sclerostin and other genes relevant to bone metabolism in humans
- (2013) Matthew M. Roforth et al. BONE
- Collagen advanced glycation inhibits its Discoidin Domain Receptor 2 (DDR2)-mediated induction of lysyl oxidase in osteoblasts
- (2013) Roozbeh Khosravi et al. BONE
- Osteocyte-Driven Bone Remodeling
- (2013) Teresita Bellido CALCIFIED TISSUE INTERNATIONAL
- The effect of dipeptidyl peptidase-IV inhibition on bone in a mouse model of type 2 diabetes
- (2013) Emily Jane Gallagher et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Exendin-4, a Glucagon-Like Peptide-1 Receptor Agonist, Prevents Osteopenia by Promoting Bone Formation and Suppressing Bone Resorption in Aged Ovariectomized Rats
- (2013) Xue Ma et al. JOURNAL OF BONE AND MINERAL RESEARCH
- In Vivo Assessment of Bone Quality in Postmenopausal Women With Type 2 Diabetes
- (2013) Joshua N Farr et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Optimal bone mechanical and material properties require a functional glucagon-like peptide-1 receptor
- (2013) Guillaume Mabilleau et al. JOURNAL OF ENDOCRINOLOGY
- Exendin-4 increases bone mineral density in type 2 diabetic OLETF rats potentially through the down-regulation of SOST/sclerostin in osteocytes
- (2013) Ju-Young Kim et al. LIFE SCIENCES
- Osteocalcin Induces Release of Glucagon-Like Peptide-1 and Thereby Stimulates Insulin Secretion in Mice
- (2013) Akiko Mizokami et al. PLoS One
- Use of glucagon-like peptide-1 receptor agonists and bone fractures: A meta-analysis of randomized clinical trials (胰高血糖素样肽-1受体激动剂的使用与骨折的关系：一项对随机临床试验的meta分析)
- (2013) Guillaume Mabilleau et al. Journal of Diabetes
- Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2012) S. E. Inzucchi et al. DIABETES CARE
- Overlap of Endocrine Hormone Expression in the Mouse Intestine Revealed by Transcriptional Profiling and Flow Cytometry
- (2012) Abdella M. Habib et al. ENDOCRINOLOGY
- GLP-1 agonists for type 2 diabetes: pharmacokinetic and toxicological considerations
- (2012) Maria J Jespersen et al. Expert Opinion on Drug Metabolism & Toxicology
- Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus
- (2012) Christine Hamann et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures
- (2012) Janina M Patsch et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sclerostin Levels Associated with Inhibition of the Wnt/β-Catenin Signaling and Reduced Bone Turnover in Type 2 Diabetes Mellitus
- (2012) Agostino Gaudio et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Circulating Sclerostin Levels and Bone Turnover in Type 1 and Type 2 Diabetes
- (2012) Luigi Gennari et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Impaired Insulin Signaling in Endothelial Cells Reduces Insulin-Induced Glucose Uptake by Skeletal Muscle
- (2011) Tetsuya Kubota et al. Cell Metabolism
- Dipeptidyl Peptidase-4 Inhibitors and Bone Fractures: A meta-analysis of randomized clinical trials
- (2011) M. Monami et al. DIABETES CARE
- Association of BMD and FRAX Score With Risk of Fracture in Older Adults With Type 2 Diabetes
- (2011) Ann V. Schwartz JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- GLP-1 and Calcitonin Concentration in Humans: Lack of Evidence of Calcitonin Release from Sequential Screening in over 5000 Subjects with Type 2 Diabetes or Nondiabetic Obese Subjects Treated with the Human GLP-1 Analog, Liraglutide
- (2011) Laszlo Hegedüs et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Liraglutide Treatment Is Associated with a Low Frequency and Magnitude of Antibody Formation with No Apparent Impact on Glycemic Response or Increased Frequency of Adverse Events: Results from the Liraglutide Effect and Action in Diabetes (LEAD) Trials
- (2011) John B. Buse et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Glucagon Like Peptide-1 Receptor Expression in the Human Thyroid Gland
- (2011) Belinda Gier et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Circulating Levels of Sclerostin Are Increased in Patients with Type 2 Diabetes Mellitus
- (2011) Antonia García-Martín et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- GLP-1 and exendin-4 can reverse hyperlipidic-related osteopenia
- (2011) Bernardo Nuche-Berenguer et al. JOURNAL OF ENDOCRINOLOGY
- New laboratory tools in the assessment of bone quality
- (2011) D. Chappard et al. OSTEOPOROSIS INTERNATIONAL
- Bone structure and turnover in type 2 diabetes mellitus
- (2011) A. Shu et al. OSTEOPOROSIS INTERNATIONAL
- Exenatide treatment did not affect bone mineral density despite body weight reduction in patients with type 2 diabetes
- (2010) M. C. Bunck et al. DIABETES OBESITY & METABOLISM
- Glucagon-Like Peptide-1 Receptor Agonists Activate Rodent Thyroid C-Cells Causing Calcitonin Release and C-Cell Proliferation
- (2010) Lotte Bjerre Knudsen et al. ENDOCRINOLOGY
- Bone loss accompanying voluntary weight loss in obese humans
- (2010) Lars Bjørn Jensen et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Two doses of sclerostin antibody in cynomolgus monkeys increases bone formation, bone mineral density, and bone strength
- (2010) Michael S Ominsky et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Presence of a functional receptor for GLP-1 in osteoblastic cells, independent of the cAMP-linked GLP-1 receptor
- (2010) Bernardo Nuche-Berenguer et al. JOURNAL OF CELLULAR PHYSIOLOGY
- High-Resolution Peripheral Quantitative Computed Tomographic Imaging of Cortical and Trabecular Bone Microarchitecture in Patients with Type 2 Diabetes Mellitus
- (2010) Andrew J. Burghardt et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pentosidine and Increased Fracture Risk in Older Adults with Type 2 Diabetes
- (2009) Ann V. Schwartz et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states
- (2009) Bernardo Nuche-Berenguer et al. REGULATORY PEPTIDES
- The Murine Glucagon-Like Peptide-1 Receptor Is Essential for Control of Bone Resorption
- (2007) Chizumi Yamada et al. ENDOCRINOLOGY
- Serum Pentosidine Levels Are Positively Associated with the Presence of Vertebral Fractures in Postmenopausal Women with Type 2 Diabetes
- (2007) Masahiro Yamamoto et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now